52 related articles for article (PubMed ID: 32860308)
1. Identification of ASF1A and HJURP by global H3-H4 histone chaperone analysis as a prognostic two-gene model in hepatocellular carcinoma.
Liu Y; Liu S; Jing R; Li C; Guo Y; Cai Z; Xi P; Dai P; Jia L; Zhu H; Zhang X
Sci Rep; 2024 Apr; 14(1):7666. PubMed ID: 38561384
[TBL] [Abstract][Full Text] [Related]
2. Silencing of
Chen D; Yan R; Xu Z; Qian J; Yu Y; Zhu S; Wu H; Zhu G; Chen M
Insects; 2022 Nov; 13(11):. PubMed ID: 36421975
[TBL] [Abstract][Full Text] [Related]
3. The histone chaperone FACT: a guardian of chromatin structure integrity.
Jeronimo C; Robert F
Transcription; 2022; 13(1-3):16-38. PubMed ID: 35485711
[TBL] [Abstract][Full Text] [Related]
4. Splice and Dice: Intronic microRNAs, Splicing and Cancer.
Wong ACH; Rasko JEJ
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572454
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of the histone chaperone FACT - Resolving FACTual issues.
Gurova K; Chang HW; Valieva ME; Sandlesh P; Studitsky VM
Biochim Biophys Acta Gene Regul Mech; 2018 Jul; ():. PubMed ID: 30055319
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of Ty 16 promotes lung cancer malignancy and is negatively regulated by miR-1227-5p.
Yang L; Wang X; Jiao X; Tian B; Zhang M; Zhou C; Wang R; Chen H; Wang B; Li J; Liu J; Zhang G; Liu P
Cancer Sci; 2020 Nov; 111(11):4075-4087. PubMed ID: 32860308
[TBL] [Abstract][Full Text] [Related]
7. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
8. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
[TBL] [Abstract][Full Text] [Related]
9. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo.
Zhang Y; Jiang WL; Yang JY; Huang J; Kang G; Hu HB; Xie S
J Cell Physiol; 2019 Aug; 234(10):18679-18687. PubMed ID: 30993701
[TBL] [Abstract][Full Text] [Related]
11. miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition.
Meng F; Zhang L
Exp Cell Res; 2019 Jan; 374(2):315-322. PubMed ID: 30528264
[TBL] [Abstract][Full Text] [Related]
12. Cancer statistics, 2019.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2019 Jan; 69(1):7-34. PubMed ID: 30620402
[TBL] [Abstract][Full Text] [Related]
13. Curaxin CBL0137 Exerts Anticancer Activity via Diverse Mechanisms.
Jin MZ; Xia BR; Xu Y; Jin WL
Front Oncol; 2018; 8():598. PubMed ID: 30581774
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
